大腸がん検診の世界市場レポート 2025年

大腸がん検診市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.1％で210億1,000万米ドルに成長します。予測期間の成長は、非侵襲的スクリーニング法への移行、在宅スクリーニング検査の増加、肥満の有病率の増加、価値観に基づくヘルスケアの採用増加、官民パートナーシップの増加などに起因すると考えられます。予測期間における主な動向には、スクリーニングと診断におけるAIの統合、若年層へのスクリーニングガイドラインの拡大、がんリスクに対するゲノム検査の広範な利用、モバイルヘルス（mヘルス）プラットフォームの成長、製薬企業と診断企業のコラボレーションなどがあります。

高齢化人口の増加は、今後数年間の大腸がん検診市場の成長を牽引すると予測されています。高齢化とは、生産年齢人口に占める高齢者（一般的に65歳以上）の割合の増加を特徴とする人口統計学的傾向を指し、多くの場合、平均寿命の延長と出生率の低下によってもたらされます。平均寿命が延び、出生率が低下するにつれ、世界人口に占める高齢者の割合は増加の一途をたどっています。大腸がん検診は、早期発見と予防措置を可能にすることで、この拡大する高齢者人口のニーズに対応する上で重要な役割を果たしています。これは、高齢者におけるがんリスクの高まりに対処し、彼らの全体的な健康アウトカムを改善するために不可欠です。例えば、2024年1月、米国を拠点とする非営利調査機関である人口問題研究所（PRB）のデータによると、65歳以上の米国人の数は、2022年の5,800万人から2050年には8,200万人に増加し、47％増になると予測されています。さらに、総人口に占める高齢者の割合は17％から23％に増加すると予想されています。このように、高齢化人口の増加は大腸がん検診市場の重要な促進要因となっています。

大腸がん検診市場の主な参入企業は、非侵襲的マルチターゲット便中リボ核酸（RNA）大腸がん検診検査などの革新的ソリューションの開発に注力し、利用しやすく効果的な早期発見法を提供することで、患者の転帰を改善し、検診への幅広い参加を促進しています。非侵襲的マルチターゲット便RNA大腸がん検診検査は、便検体からRNAマーカーを評価し、大腸がんや前がん病変の存在を同定し、早期発見のための非外科的アプローチを提供します。例えば、2024年5月、米国のライフサイエンス企業であるGeneoscopy Inc.は、ColoSenseの米国食品医薬品局（FDA）承認を取得したと発表しました。この検査はRNAバイオマーカーを利用した非侵襲的な便ベースのスクリーニング法で、大腸がんの検出感度は93％、進行腺腫の検出感度は45％でした。この検査の意義は、特に若年層における精度の高さと、従来の検査法に代わる低侵襲な検査法を提供することで検診率を向上させる可能性にあります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界大腸がん検診 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の大腸がん検診市場：成長率分析
• 世界の大腸がん検診市場の実績：規模と成長, 2019-2024
• 世界の大腸がん検診市場の予測：規模と成長, 2024-2029, 2034F
• 世界大腸がん検診総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の大腸がん検診市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 便に基づく
• 便潜血検査（FIT）
• 便潜血検査（FOBT）
• 便中デオキシリボ核酸（DNA）検査
• 大腸内視鏡検査
• その他のタイプ
• 世界の大腸がん検診市場：年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 50歳未満
• 50～64歳
• 65歳以上
• 世界の大腸がん検診市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 臨床検査室
• 診断画像センター
• その他のエンドユーザー
• 世界の大腸がん検診市場、便検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 便検査
• 世界の大腸がん検診市場便潜血検査（FIT）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 高感度FIT
• 低感度FIT
• 世界の大腸がん検診市場便潜血検査（FOBT）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• グアイアックFOBT
• 免疫化学的FOBT
• 世界の大腸がん検診市場便中デオキシリボ核酸（DNA）検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• マルチターゲット便DNA検査
• 単一ターゲット便DNA検査
• 世界の大腸がん検診市場大腸内視鏡検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断的大腸内視鏡検査
• 治療的大腸内視鏡検査
• 世界の大腸がん検診市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バーチャル大腸内視鏡検査
• フレキシブルS状結腸鏡検査
• カプセル内視鏡検査

第7章 地域別・国別分析

• 世界の大腸がん検診市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の大腸がん検診市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 大腸がん検診市場：競合情勢
• 大腸がん検診市場：企業プロファイル
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• FUJIFILM Holdings Corporation
• GE HealthCare
• Boston Scientific Corporation
• Olympus Corporation
• Hologic Inc.
• bioMerieux SA
• QuidelOrtho Corporation
• Sysmex Corporation
• QIAGEN N.V.
• Exact Sciences Corporation
• Guardant Health Inc.
• Eiken Chemical Co. Ltd.
• HemoCue AB
• Clinical Genomics Inc.
• Polymedco LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 大腸がん検診市場2029：新たな機会を提供する国
• 大腸がん検診市場2029：新たな機会を提供するセグメント
• 大腸がん検診市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Colorectal cancer screening refers to testing procedures aimed at detecting early signs of colorectal cancer before symptoms manifest. Early detection through screening can identify precancerous polyps or cancer at a more treatable stage, significantly enhancing patient outcomes. Screening is recommended for adults starting at age 45, or earlier for those at higher risk.

The primary types of colorectal cancer screening include stool-based tests, fecal immunochemical tests (FIT), fecal occult blood tests (FOBT), stool deoxyribonucleic acid (DNA) tests, and colonoscopy, among others. Stool-based colorectal cancer screening involves analyzing a stool sample for indicators of cancer-related substances or abnormalities, such as blood or DNA mutations, to identify potential colorectal cancer. These screenings are categorized by age groups, including individuals under 50, those aged 50-64, and those over 65. The end users of these tests encompass hospitals and clinics, clinical laboratories, diagnostic imaging centers, and other healthcare providers.

The colorectal cancer screening market research report is one of a series of new reports from The Business Research Company that provides colorectal cancer screening market statistics, including colorectal cancer screening industry global market size, regional shares, competitors with a colorectal cancer screening market share, detailed colorectal cancer screening market segments, market trends and opportunities, and any further data you may need to thrive in the colorectal cancer screening industry. This colorectal cancer screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The colorectal cancer screening market size has grown strongly in recent years. It will grow from $15.61 billion in 2024 to $16.6 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to the increasing incidence of colorectal cancer, rising government awareness campaigns, an aging population, growing adoption of colonoscopy, and improved insurance coverage.

The colorectal cancer screening market size is expected to see strong growth in the next few years. It will grow to $21.01 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to a shift to non-invasive screening methods, increasing home-based screening tests, growing prevalence of obesity, rising adoption of value-based healthcare, and increasing public-private partnerships. Major trends in the forecast period include the integration of AI in screening and diagnostics, expansion of screening guidelines to younger populations, broader use of genomic testing for cancer risk, growth in mobile health (mHealth) platforms, and collaborations between pharmaceutical and diagnostic companies.

The increasing aging population is projected to drive the growth of the colorectal cancer screening market in the coming years. An aging population refers to a demographic trend characterized by a rising proportion of elderly individuals (typically those aged 65 and older) relative to the working-age population, often resulting from longer life expectancies and declining birth rates. As life expectancies increase and birth rates decline, the share of older adults in the global population continues to grow. Colorectal cancer screening plays a crucial role in addressing the needs of this expanding aging population by enabling early detection and preventive measures, which are essential for managing the heightened cancer risk among older adults and improving their overall health outcomes. For example, in January 2024, data from the Population Reference Bureau (PRB), a U.S.-based nonprofit research organization, projected that the number of Americans aged 65 and older would rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, their share of the total population is expected to grow from 17% to 23%. Thus, the increasing aging population is a significant driver of the colorectal cancer screening market.

Key players in the colorectal cancer screening market are focusing on developing innovative solutions, such as non-invasive multi-target stool ribonucleic acid (RNA) colorectal cancer screening tests, to provide accessible and effective early detection methods, thereby improving patient outcomes and promoting wider screening participation. Non-invasive multi-target stool RNA colorectal cancer screening tests evaluate RNA markers from stool samples to identify the presence of colorectal cancer or precancerous lesions, offering a non-surgical approach for early detection. For instance, in May 2024, Geneoscopy Inc., a U.S.-based life sciences company, announced that it received U.S. Food and Drug Administration (FDA) approval for ColoSense. This test utilizes RNA biomarkers for a non-invasive, stool-based screening method that demonstrated 93% sensitivity in detecting colorectal cancer and 45% sensitivity for advanced adenomas. Its significance lies in its high accuracy, particularly among younger populations, and its potential to enhance screening rates by providing a less invasive alternative to traditional methods.

In November 2023, Geneoscopy Inc. partnered with Laboratory Corporation (LabCorp), a U.S.-based life science and healthcare company, to broaden access to Geneoscopy's non-invasive multi-target stool RNA colorectal cancer screening test. This collaboration aims to improve early and sensitive detection of colorectal cancer and precancerous lesions, address health disparities, and increase screening rates by leveraging LabCorp's extensive network of healthcare providers and patients. LabCorp is known for offering colon cancer screening and diagnostic tests.

Major companies operating in the colorectal cancer screening market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers, FUJIFILM Holdings Corporation, GE HealthCare, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., Eiken Chemical Co. Ltd., HemoCue AB, Clinical Genomics Inc., Polymedco LLC, Hemosure Inc., Geneoscopy Inc., Novigenix SA

North America was the largest region in the colorectal cancer screening market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the colorectal cancer screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The colorectal cancer screening market includes revenues earned by entities by providing services such as genetic and molecular testing, patient education and awareness programs, and screening result analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Colorectal Cancer Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on colorectal cancer screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for colorectal cancer screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The colorectal cancer screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Stool-Based; Fecal Immunochemical Test (FIT); Fecal Occult Blood Test (FOBT); Stool Deoxyribonucleic Acid (DNA) Test; Colonoscopy; Other Types
• 2) By Age Group: Below 50 Years; 50-64 Years; Above 65 Years
• 3) By End User: Hospitals And Clinics; Clinical Laboratories; Diagnostic Imaging Centers; Other End-Users
• Subsegments:
• 1) By Stool-Based Tests: Stool-Based Tests
• 2) By Fecal Immunochemical Test (FIT): High-Sensitivity FIT; Low-Sensitivity FIT
• 3) By Fecal Occult Blood Test (FOBT): Guaiac FOBT; Immunochemical FOBT
• 4) By Stool Deoxyribonucleic Acid (DNA) Test: Multi-Target Stool DNA Test; Single-Target Stool DNA Test
• 5) By Colonoscopy: Diagnostic Colonoscopy; Therapeutic Colonoscopy
• 6) By Other Types: Virtual Colonoscopy; Flexible Sigmoidoscopy; Capsule Endoscopy
• Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Medtronic plc; Siemens Healthineers
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Colorectal Cancer Screening Market Characteristics

3. Colorectal Cancer Screening Market Trends And Strategies

4. Colorectal Cancer Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Colorectal Cancer Screening Growth Analysis And Strategic Analysis Framework

• 5.1. Global Colorectal Cancer Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Colorectal Cancer Screening Market Growth Rate Analysis
• 5.4. Global Colorectal Cancer Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Colorectal Cancer Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Colorectal Cancer Screening Total Addressable Market (TAM)

6. Colorectal Cancer Screening Market Segmentation

• 6.1. Global Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stool-Based
• Fecal Immunochemical Test (FIT)
• Fecal Occult Blood Test (FOBT)
• Stool Deoxyribonucleic Acid (DNA) Test
• Colonoscopy
• Other Types
• 6.2. Global Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Below 50 Years
• 50-64 Years
• Above 65 Years
• 6.3. Global Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Clinical Laboratories
• Diagnostic Imaging Centers
• Other End-Users
• 6.4. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Stool-Based Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stool-Based Tests
• 6.5. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Fecal Immunochemical Test (FIT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High-Sensitivity FIT
• Low-Sensitivity FIT
• 6.6. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Fecal Occult Blood Test (FOBT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Guaiac FOBT
• Immunochemical FOBT
• 6.7. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Stool Deoxyribonucleic Acid (DNA) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Multi-Target Stool DNA Test
• Single-Target Stool DNA Test
• 6.8. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Colonoscopy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Colonoscopy
• Therapeutic Colonoscopy
• 6.9. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Virtual Colonoscopy
• Flexible Sigmoidoscopy
• Capsule Endoscopy

7. Colorectal Cancer Screening Market Regional And Country Analysis

• 7.1. Global Colorectal Cancer Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Colorectal Cancer Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Colorectal Cancer Screening Market

• 8.1. Asia-Pacific Colorectal Cancer Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Colorectal Cancer Screening Market

• 9.1. China Colorectal Cancer Screening Market Overview
• 9.2. China Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Colorectal Cancer Screening Market

• 10.1. India Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Colorectal Cancer Screening Market

• 11.1. Japan Colorectal Cancer Screening Market Overview
• 11.2. Japan Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Colorectal Cancer Screening Market

• 12.1. Australia Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Colorectal Cancer Screening Market

• 13.1. Indonesia Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Colorectal Cancer Screening Market

• 14.1. South Korea Colorectal Cancer Screening Market Overview
• 14.2. South Korea Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Colorectal Cancer Screening Market

• 15.1. Western Europe Colorectal Cancer Screening Market Overview
• 15.2. Western Europe Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Colorectal Cancer Screening Market

• 16.1. UK Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Colorectal Cancer Screening Market

• 17.1. Germany Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Colorectal Cancer Screening Market

• 18.1. France Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Colorectal Cancer Screening Market

• 19.1. Italy Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Colorectal Cancer Screening Market

• 20.1. Spain Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Colorectal Cancer Screening Market

• 21.1. Eastern Europe Colorectal Cancer Screening Market Overview
• 21.2. Eastern Europe Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Colorectal Cancer Screening Market

• 22.1. Russia Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Colorectal Cancer Screening Market

• 23.1. North America Colorectal Cancer Screening Market Overview
• 23.2. North America Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Colorectal Cancer Screening Market

• 24.1. USA Colorectal Cancer Screening Market Overview
• 24.2. USA Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Colorectal Cancer Screening Market

• 25.1. Canada Colorectal Cancer Screening Market Overview
• 25.2. Canada Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Colorectal Cancer Screening Market

• 26.1. South America Colorectal Cancer Screening Market Overview
• 26.2. South America Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Colorectal Cancer Screening Market

• 27.1. Brazil Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Colorectal Cancer Screening Market

• 28.1. Middle East Colorectal Cancer Screening Market Overview
• 28.2. Middle East Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Colorectal Cancer Screening Market

• 29.1. Africa Colorectal Cancer Screening Market Overview
• 29.2. Africa Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Colorectal Cancer Screening Market Competitive Landscape And Company Profiles

• 30.1. Colorectal Cancer Screening Market Competitive Landscape
• 30.2. Colorectal Cancer Screening Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

31. Colorectal Cancer Screening Market Other Major And Innovative Companies

• 31.1. FUJIFILM Holdings Corporation
• 31.2. GE HealthCare
• 31.3. Boston Scientific Corporation
• 31.4. Olympus Corporation
• 31.5. Hologic Inc.
• 31.6. bioMerieux SA
• 31.7. QuidelOrtho Corporation
• 31.8. Sysmex Corporation
• 31.9. QIAGEN N.V.
• 31.10. Exact Sciences Corporation
• 31.11. Guardant Health Inc.
• 31.12. Eiken Chemical Co. Ltd.
• 31.13. HemoCue AB
• 31.14. Clinical Genomics Inc.
• 31.15. Polymedco LLC

32. Global Colorectal Cancer Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Colorectal Cancer Screening Market

34. Recent Developments In The Colorectal Cancer Screening Market

35. Colorectal Cancer Screening Market High Potential Countries, Segments and Strategies

• 35.1 Colorectal Cancer Screening Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Colorectal Cancer Screening Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Colorectal Cancer Screening Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer